| Bioactivity | Thalidomide-O-amido-PEG2-C2-NH2 incorporates an E3 ligase ligand and a linker, can be an immunomodulater for the treatment of cancer. |
| Invitro | PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins. |
| Name | Thalidomide-O-amido-PEG2-C2-NH2 |
| CAS | 1957235-74-3 |
| Formula | C21H26N4O8 |
| Molar Mass | 462.45 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. ARYL SULFONOHYDRAZIDES. WO 2017/176958 A1. |
Thalidomide-O-amido-PEG2-C2-NH2
CAS: 1957235-74-3 F: C21H26N4O8 W: 462.45
Thalidomide-O-amido-PEG2-C2-NH2 incorporates an E3 ligase ligand and a linker, can be an immunomodulater for the treatme
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.